The Case Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1826-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.case.edu/cancer
11C Topotecan PET Imaging
- Conditions
- Lung CancerMetastatic CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2005-11-15
- Last Posted Date
- 2012-03-20
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT00253461
- Locations
- 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
- Conditions
- Breast CancerDrug/Agent Toxicity by Tissue/OrganEndometrial CancerFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
- Interventions
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2011-12-30
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 34
- Registration Number
- NCT00245050
- Locations
- 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸University Suburban Health Center, Cleveland, Ohio, United States
🇺🇸Geauga Regional Hospital, Cleveland, Ohio, United States
Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-10-26
- Last Posted Date
- 2011-05-04
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 348
- Registration Number
- NCT00244309
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
High Light and Low Light Dose PDT in Glioma
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT00118222
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
- Conditions
- Cervical CancerEndometrial CancerOvarian CancerVaginal Cancer
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2011-07-08
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT00118300
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Biological: bevacizumab
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2012-09-03
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00118261
- Locations
- 🇺🇸
MetroHealth Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States
🇺🇸UHHS Chagrin Highlands Medical Center, Cleveland, Ohio, United States
🇺🇸Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Campath-1H + FK506 and Methylprednisolone for GVHD
- Conditions
- Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic TumorGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative DiseasesNeuroblastoma
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 34
- Registration Number
- NCT00109993
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Mt. Sinai Medical Center, New York, New York, United States
🇺🇸Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT00110006
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
- Conditions
- LymphomaNon-melanomatous Skin CancerPrecancerous Condition
- Interventions
- First Posted Date
- 2005-02-08
- Last Posted Date
- 2019-01-22
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 43
- Registration Number
- NCT00103246
- Locations
- 🇺🇸
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Liposomal Doxorubicin in Treating Patients With Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-09-14
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00004014
- Locations
- 🇺🇸
Ireland Cancer Center at University Hospitals Case Medical Center, Cleveland, Ohio, United States